CASCOM Study: CAR Score Predicting Restroke in Symptomatic Carotid Stenosis With Only Intensive Medical Therapy
Stroke · 2025
DOI: 10.1161/strokeaha.125.052151 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Stroke, 2025. Verfasst von Saeid Shahidi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular and Endovascular Surgery (S.S., E.N.E., M.B., A.P., S.A.Z.), Zealand University Hospital, Roskilde, Denmark. Hauptthemen laut MEDLINE: Carotid Stenosis, Stroke. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Carotid endarterectomy for symptomatic carotid stenosis is based on decades-old trials, while modern medical therapy has substantially improved outcomes. The carotid artery risk (CAR) score predicts stroke risk using clinical and imaging factors. This study evaluates the 2-year risk of recurrent ipsilateral stroke in patients with recent transient ischemic attack, amaurosis fugax, or minor stroke and ipsilateral symptomatic carotid stenosis treated with intensive medical therapy. METHODS: In this prospective, single-arm observational study conducted in Denmark from October 2020 to March 2023, we enrolled 109 patients with recent TIA, amaurosis fugax, or minor stroke and 50% to 99% ipsilateral symptomatic carotid stenosis. Patients with a CAR score ≤20% or >20%, as well as those with contraindications to surgery, were included. All received intensive medical therapy. The primary outcome was ipsilateral recurrent stroke or death within 2 years. RESULTS: The mean age was 73 years; 60% were male patients. Six patients (5.5%) experienced ipsilateral recurrent stroke, representing a ≈75% reduction compared with historical NASCET (North American Symptomatic Carotid Endarterectomy Trial) rates (≈23%). Patients with CAR score ≤20% (n=96) had a significantly lower 2-year stroke rate (3.1%) than those with CAR score >20% (n=13; 23%; P =0.02). The CAR score ≤20% subgroup showed high predictive accuracy: sensitivity of 0.90, specificity of 0.50, and positive predictive value of 0.97. CONCLUSIONS: In this observational study, modern medical therapy was associated with low rates of recurrent stroke in patients with symptomatic carotid stenosis. Patients with a CAR score ≤20% had a very low risk of recurrent stroke, suggesting that selected patients may be managed conservatively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Vascular and Endovascular Surgery (S.S., E.N.E., M.B., A.P., S.A.Z.), Zealand University Hospital, Roskilde, Denmark.
- Faculty of Health and Medical Sciences, Department of Clinical Medicine, University of Copenhagen and Zealand, Denmark (S.S., T.W.).
- Department of Neurology (T.W.), Zealand University Hospital, Roskilde, Denmark.
- Department of Vascular Surgery, Rigshospitalet, Copenhagen, Denmark (E.N.E.).
ORCID-Profile: Saeid Shahidi, Troels Wienecke, Magdalena Broda, Stefan Andreas Zambach
Zitieren
APA
Shahidi, S., Wienecke, T., Noeddeskov Eilersen, E., Broda, M., Pelta, A., & Zambach, S. A. (2025). CASCOM Study: CAR Score Predicting Restroke in Symptomatic Carotid Stenosis With Only Intensive Medical Therapy. Stroke. https://doi.org/10.1161/strokeaha.125.052151
Vancouver
Shahidi S, Wienecke T, Noeddeskov Eilersen E, Broda M, Pelta A, Zambach SA. CASCOM Study: CAR Score Predicting Restroke in Symptomatic Carotid Stenosis With Only Intensive Medical Therapy. Stroke. 2025. doi:10.1161/strokeaha.125.052151
BibTeX
@article{Shahidi2025,
author = {Shahidi, Saeid and Wienecke, Troels and Noeddeskov Eilersen, Emilie and Broda, Magdalena and Pelta, Anna and Zambach, Stefan Andreas},
title = {CASCOM Study: CAR Score Predicting Restroke in Symptomatic Carotid Stenosis With Only Intensive Medical Therapy},
journal = {Stroke},
year = {2025},
doi = {10.1161/strokeaha.125.052151}
}
EUVIMED